arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA

$35.35 ▲ +0.54 (+1.55%) at close

16 Visible periods

33 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

TEVA PHARMACEUTICAL INDUSTRIES LTD shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $40.5B

Dividend Yield —

Revenue Growth 4.3% ↘

Op. Margin 12.5% ↗

ROIC 21.5% ↗

FCF / Share $1.44 ↗

Trailing P/E 28.7x

Price / Book 5.1x

FCF Yield 4.1%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$17.26B

↑ +4.3% —

Net Income Profit after all expenses

$1.41B

↑ +186.0% —

Operating Margin Operating profit as % of sales

12.5%

↑ +782.4% 62th

FCF / Share Free cash flow per share

$1.44

↑ +30.6% —

Long-Term Debt Long-term obligations

$14.14B

↑ +24.1% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

$0.74

FY 2014

$0.89

FY 2015

$1.03

FY 2016

$0.85

FY 2017

$0.00

FY 2018

$0.00

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2012 20-F ↗	FY 2015 Dec 31, 2011 20-F ↗	FY 2014 Dec 31, 2010 20-F ↗	FY 2013 Dec 31, 2009 20-F ↗	FY 2012 Dec 31, 2008 20-F ↗	FY 2011 Dec 31, 2007 20-F ↗	FY 2010 Dec 31, 2006 20-F ↗
Revenue Growth YoY (%)	4.3% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-46%)	4.4% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-45%)	6.2% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-23%)	-6.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-175%)	-4.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-159%)	-1.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-117%)	-7.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-195%)	-18.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-330%)	10.2% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+27%)	10.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+37%)	13.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+70%)	16.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+100%)	25.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+217%)	17.8% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+123%)	—	—
EPS Growth YoY (%)	N/M	-190.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	76.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-300.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	61.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	85.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-27.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-16.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	62.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	193.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-68.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	N/M	-193.2% Weak Weak Year-over-year change in net income	76.2% Excellent Excellent Year-over-year change in net income	N/M	N/M	-299.4% Weak ↓ Weak Declining Year-over-year change in net income	53.5% Excellent ↑ Excellent Improving Year-over-year change in net income	86.8% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-28.9% Weak ↓ Weak Declining Year-over-year change in net income	-17.2% Weak ↓ Weak Declining Year-over-year change in net income	66.5% Excellent ↓ Excellent Declining Year-over-year change in net income	228.4% Excellent Excellent Year-over-year change in net income	-68.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	30.6% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	-9.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	30.2% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	338.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-63.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	185.1% Excellent Excellent Year-over-year change in free cash flow	-88.4% Weak Weak Year-over-year change in free cash flow	—	—	14.9% Fair ↑ Fair Improving Year-over-year change in free cash flow	-9.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	25.6% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	-6.9% Weak Weak Year-over-year change in free cash flow	97.5% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	5.0% Caution ↑ Caution Improving Compound annual revenue growth over 3 years	1.4% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-1.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-4.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-4.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-9.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-6.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-0.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	11.6% Good ↓ Good Declining Compound annual revenue growth over 3 years	13.5% Good ↓ Good Declining Compound annual revenue growth over 3 years	18.2% Excellent Excellent Compound annual revenue growth over 3 years	19.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	0.7% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-0.4% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-2.8% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-7.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-4.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-1.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	0.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	5.6% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	15.1% Excellent Excellent Compound annual revenue growth over 5 years	16.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	-0.6% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	58.4% Excellent Excellent Compound annual EPS growth over 3 years	14.3% Good Good Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2012 20-F ↗	FY 2015 Dec 31, 2011 20-F ↗	FY 2014 Dec 31, 2010 20-F ↗	FY 2013 Dec 31, 2009 20-F ↗	FY 2012 Dec 31, 2008 20-F ↗	FY 2011 Dec 31, 2007 20-F ↗	FY 2010 Dec 31, 2006 20-F ↗
Operating Margin (%) (%)	12.5% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-17%)	-1.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-112%)	2.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-82%)	-14.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-194%)	10.8% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-28%)	-21.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-243%)	-2.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-117%)	-9.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-160%)	-78.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-621%)	10.9% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-28%)	17.0% Fair → Fair Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+13%)	24.0% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+60%)	17.3% Fair → Fair Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+15%)	10.3% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-31%)	25.5% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+70%)	—
Profit Margin (%) (%)	8.2% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-32%)	-9.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-183%)	-3.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-129%)	-15.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-231%)	2.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-78%)	-24.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-300%)	-5.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-149%)	-11.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-198%)	-72.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-706%)	9.7% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-19%)	15.1% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+26%)	20.7% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+72%)	14.4% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+20%)	5.5% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-54%)	20.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+70%)	—
FCF Margin (%) (%)	9.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	7.5% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	8.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	7.0% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	1.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	3.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	1.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	9.8% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	6.0% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	17.1% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	16.8% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	21.3% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	19.1% Good → Good Stable Free cash flow as a percentage of revenue Optimal: > 10%	23.0% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	13.5% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.76x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	-2.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.16x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.22x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.83x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.77x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	4.19x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2012 20-F ↗	FY 2015 Dec 31, 2011 20-F ↗	FY 2014 Dec 31, 2010 20-F ↗	FY 2013 Dec 31, 2009 20-F ↗	FY 2012 Dec 31, 2008 20-F ↗	FY 2011 Dec 31, 2007 20-F ↗	FY 2010 Dec 31, 2006 20-F ↗
Return on Invested Capital (%)	21.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.6% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.2% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-79.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.7% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	7.3% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	11.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	5.5% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	5.3% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-0.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	3.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	4.4% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	6.2% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	10.1% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	7.2% Fair Fair Operating profit relative to total assets Optimal: > 10%	3.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	17.8% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+19%)	-30.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-303%)	-7.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-29.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	4.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-73%)	-39.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	-7.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-14.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-93.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-725%)	8.6% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-43%)	12.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	15.2% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	10.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	3.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2012 20-F ↗	FY 2015 Dec 31, 2011 20-F ↗	FY 2014 Dec 31, 2010 20-F ↗	FY 2013 Dec 31, 2009 20-F ↗	FY 2012 Dec 31, 2008 20-F ↗	FY 2011 Dec 31, 2007 20-F ↗	FY 2010 Dec 31, 2006 20-F ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	0.62x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.51x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-14%)	0.22x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	0.21x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	—	—	—
Interest Coverage (x)	2.35x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-0.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	1.93x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-3.71x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.78x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-19.98x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	6.21x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	13.29x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	19.16x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	10.46x Excellent → Excellent Stable Operating income divided by interest expense Optimal: > 5x	7.44x Good Good Operating income divided by interest expense Optimal: > 5x	13.38x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-3.56B	$-3.30B	$-3.23B	$-2.80B	$-2.17B	$-2.18B	$-1.98B	$-1.78B	$-963.00M	$11.26B	$10.30B	$3.54B	$2.06B	$-1.85B	$-1.49B	$-1.33B
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	5.37x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.29x Caution ↑ Caution Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.11x Good Good Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.43x Good Good Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2012 20-F ↗	FY 2015 Dec 31, 2011 20-F ↗	FY 2014 Dec 31, 2010 20-F ↗	FY 2013 Dec 31, 2009 20-F ↗	FY 2012 Dec 31, 2008 20-F ↗	FY 2011 Dec 31, 2007 20-F ↗	FY 2010 Dec 31, 2006 20-F ↗
Revenue per Share (USD)	$15.07	$14.63	$14.16	$13.45	$14.41	$15.21	$15.48	$17.90	—	$23.30	$20.58	$17.99	$15.94	$14.21	$12.25	—
Basic EPS, GAAP (USD)	$1.23	$-1.45	$-0.50	$-2.12	$0.38	$-3.64	$-0.91	$-2.35	$-16.26	$2.25	$3.10	$3.72	$2.29	$0.78	$2.49	—
Free Cash Flow per Share (USD)	$1.44	$1.10	$1.22	$0.94	$0.21	$0.58	$0.20	$1.76	—	$3.98	$3.46	$3.82	$3.04	$3.27	$1.65	—
Dividend per Share (USD)	—	—	—	—	—	—	$0.00	$0.00	$0.85	$1.03	$0.89	$0.74	$0.61	—	—	—
Book Value per Share (USD)	$6.91	$4.75	$6.71	$7.11	$9.33	$9.16	$12.81	$14.40	—	$26.11	$24.94	$23.42	$20.83	$18.42	—	—
Tangible Book Value per Share (USD)	$-7.07	$-8.64	$-8.64	$-8.77	$-8.86	$-9.68	$-9.97	$-10.00	—	$-4.40	$-7.21	$1.03	$2.70	$-0.56	—	—
Basic Weighted Avg Shares (shares)	1.15B	1.13B	1.12B	1.11B	1.10B	1.09B	1.09B	1.02B	1,016	872.00M	890.00M	896.00M	872.00M	780.00M	768.00M	—
Dividend Payout Ratio (%)	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	-5.2% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	45.8% Good ↑ Good Improving Dividends paid as a percentage of earnings Optimal: 30-60%	28.7% Excellent ↑ Excellent Improving Dividends paid as a percentage of earnings Optimal: 30-60%	19.9% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	26.6% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2012 20-F ↗	FY 2015 Dec 31, 2011 20-F ↗	FY 2014 Dec 31, 2010 20-F ↗	FY 2013 Dec 31, 2009 20-F ↗	FY 2012 Dec 31, 2008 20-F ↗	FY 2011 Dec 31, 2007 20-F ↗	FY 2010 Dec 31, 2006 20-F ↗
Working Capital (USD)	$490.00M	$-244.00M	$238.00M	$582.00M	$1.55B	$-159.00M	$-210.00M	$-528.00M	$-2.54B	$3.47B	$777.00M	$2.35B	$4.54B	$2.94B	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	$14.14B	$11.39B	$4.79B	$4.06B	—	—	—
Total Equity (USD)	$7.91B	$5.37B	$7.51B	$7.90B	$10.28B	$10.03B	$13.97B	$14.71B	$17.36B	$22.77B	$22.20B	$21.95B	$19.22B	$16.38B	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2012 20-F ↗	FY 2015 Dec 31, 2011 20-F ↗	FY 2014 Dec 31, 2010 20-F ↗	FY 2013 Dec 31, 2009 20-F ↗	FY 2012 Dec 31, 2008 20-F ↗	FY 2011 Dec 31, 2007 20-F ↗	FY 2010 Dec 31, 2006 20-F ↗
Sales/Revenue/Turnover (USD)	$17.26B	$16.54B	$15.85B	$14.93B	$15.88B	$16.66B	$16.89B	$18.27B	$22.39B	$20.32B	$18.31B	$16.12B	$13.90B	$11.09B	$9.41B	—
Depreciation Expense (USD)	$421.00M	$471.00M	$537.00M	$576.00M	$528.00M	$537.00M	$609.00M	$676.00M	$632.00M	$428.00M	$358.00M	$448.00M	$426.00M	—	—	—
Net Income, GAAP (USD)	$1.41B	$-1.64B	$-559.00M	$-2.35B	$417.00M	$-3.99B	$-999.00M	$-2.15B	$-16.27B	$1.96B	$2.76B	$3.33B	$2.00B	$609.00M	$1.91B	—
Operating Cash Flow (USD)	$1.65B	$1.25B	$1.37B	$1.59B	$798.00M	$1.22B	$748.00M	$2.45B	$2.23B	$4.57B	$4.13B	$4.14B	$3.37B	$3.23B	$1.81B	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 45 quarters

TEVA PHARMACEUTICAL INDUSTRIES LTD

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TEVA with peers